Skip to Content

BrightPath Biotherapeutics Co Ltd 4594 Stock Quote

| Rating as of

Morningstar‘s Stock Analysis 4594

Currency in JPY
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Key Statistics 4594

Company Profile 4594

Business Description

BrightPath Biotherapeutics Co Ltd is a biopharmaceutical venture company. It is engaged in developing novel cancer immunotherapeutics. Its products include two candidate products: ITK-1 and GRN-1201 which are in the clinical trial stage.

2-2-4 Kojimachi, Kojimachi Central Building 7th Floor
Tokyo, Japan
Industry Biotechnology
Most Recent Earnings Jun 30, 2022
Fiscal Year End Mar 31, 2020
Employees 44